Latest
The Physical and Mental Health Effects of Chemical Abortion
In 2000, the U.S. Food and Drug Administration (FDA) approved two drugs, mifepristone and misoprostol (mifepristone and misoprostol may also be referred to as chemical abortion, abortion with pills, drugs, and medication), for the sole purpose of terminating a pregnancy.
AFPI Urges Congress: Stop Forcing Americans to Pay for Abortions
Today, the America First Policy Institute (AFPI), urged Congress to stop using taxpayer dollars to fund abortions.
AFPI Opposes FDA Approval of Generic Abortion Drug
Recently, the U.S. Food and Drug Administration (FDA) approved the second generic version of the abortion drug known as mifepristone. The America First Policy Institute (AFPI) issued the following statement in response.
AFPI Appoints Bob Unanue as Chair of the America Combats Trafficking (ACT) Initiative
Today, the America First Policy Institute (AFPI) proudly announced the formation of the America Combats Trafficking Initiative, a bold national effort to convene leaders and develop America First policies in the fight to eradicate human trafficking.
AFPI Celebrates Nationwide Children’s Hospital for Ending Dangerous Drug Treatment for Minors
Emily Moreno, Deputy Director of State Action and Executive Director of AFPI's Ohio Chapter commends Nationwide Children's Hospital for its courageous and principled decision on September 5, 2025, to cease providing dangerous, life-altering drugs to minor children under the guise of "affirming" care. This decision reflects a commitment to prioritizing the long-term health and well-being of young patients over ideological and political pressures.